Paper
12 September 2003 Interstitial laser coagulation of benign prostatic hyperplasia: a minimally invasive treatment alternative
Robert F. Ordonez, Bernhard T. Mittemeyer M.D., David R. Aronoff, Werner T. W. de Riese
Author Affiliations +
Abstract
The use of minimally invasive treatments for benign prostatic hyperplasia (BPH) have been introduced into the medical community. Over the last decade several minimally invasive treatment techniques have been approved for use. In particular, interstitial laser coagulation (ILC) has shown pomise as an alternative to the current gold standard, transurethral resection of prostate (TURP). Studies show ILC to have equal efficacy as TURP while causing less side effects. Future technical advances as well as increased physician experience with ILC could lead to the replacement of TURP as the gold standard in trestment of BPH.
© (2003) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Robert F. Ordonez, Bernhard T. Mittemeyer M.D., David R. Aronoff, and Werner T. W. de Riese "Interstitial laser coagulation of benign prostatic hyperplasia: a minimally invasive treatment alternative", Proc. SPIE 4949, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems XIII, (12 September 2003); https://doi.org/10.1117/12.476511
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Prostate

Laser coagulation

Laser therapeutics

Gold

Bladder

Semiconductor lasers

Neck

Back to Top